Hanik KholidahThe rising frequency of high-profile foodborne illness outbreaks has intensified public concern regarding the safety of the global food supply chain and the subsequent medical interventions required to treat infections.…
Susilo Wagino MulyoThe landscape of treating obstructive sleep apnea (OSA), a pervasive condition affecting millions globally, is undergoing a significant transformation with the emergence of glucagon-like peptide-1 (GLP-1) receptor agonists. While medications…
Susilo Wagino MulyoThe landscape of treating Obstructive Sleep Apnea (OSA) is undergoing a significant transformation with the emergence of Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications initially developed for type…
Hanik KholidahThe landscape of modern psychiatry is facing a potential paradigm shift as new clinical data suggests that the long-standing model of daily pharmacological intervention for depression may eventually be supplemented,…
Susilo Wagino MulyoThe treatment paradigm for obstructive sleep apnea (OSA) is undergoing a significant transformation with the emergence of glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications initially developed for type…
Susilo Wagino MulyoThe landscape of managing obstructive sleep apnea (OSA) is undergoing a significant transformation, driven in part by the increasing use of Glucagon-like peptide-1 receptor agonists (GLP-1s). These medications, initially developed…
Susilo Wagino MulyoThe emergence of Glucagon-like peptide-1 receptor agonists (GLP-1s), such as Ozempic and the recently FDA-approved Zepbound, has opened new avenues in the treatment of obstructive sleep apnea (OSA), particularly for…
Pranda MichaelaThis month, after more than a decade of persistent advocacy and the invaluable input of over 14,000 patients and health professionals, polycystic ovary syndrome (PCOS) has officially been renamed. The…
Susilo Wagino MulyoThe treatment paradigm for obstructive sleep apnea (OSA) is undergoing a significant transformation, propelled by the emergence of Glucagon-like peptide-1 receptor agonists (GLP-1s). While popular GLP-1s like Ozempic have garnered…
Susilo Wagino MulyoThe landscape of sleep apnea treatment is undergoing a significant transformation with the emergence of Glucagon-like Peptide-1 (GLP-1) receptor agonists, a class of medications initially developed for type 2 diabetes.…
